Prophylactic Use of an Implantable Cardioverter–Defibrillator after Acute Myocardial Infarction

Top Cited Papers
Open Access
Abstract
Implantable cardioverter–defibrillator (ICD) therapy has been shown to improve survival in patients with various heart conditions who are at high risk for ventricular arrhythmias. Whether benefit occurs in patients early after myocardial infarction is unknown.